Happy Holidays and DPC’s Top 10 Accomplishments of 2019

2020-03-21T20:40:48+00:00December 20th, 2019|Categories: 5-Star Ratings, About DPC, Access to Transplant, Article, Care Coordination, Charitable Premium Assistance, Dental Coverage, Dialysis Funding, Immunosuppressive Drug Coverage, Innovation, Medicaid, Medicare Advantage, Medigap Coverage, Quality Incentive Program, Transplant Donor Protection, Transportation Services, Treatment Options|

Dialysis Patient Citizens wants to wish you and your family a Happy Holiday, as well as a safe and healthy New Year. Our offices will be closed for the holidays starting December 23 through January 1. We also want to take this opportunity to share our list of Top 10 Accomplishments for 2019, which would not have been possible without your support. Thank you again for helping us elevate the dialysis patient voice with policy makers. We are extremely grateful for all of your advocacy efforts, and we look forward to our continued collaboration in 2020 as we work together to improve dialysis [...]

DPC Comments on CMS Proposed ESRD Annual Payment Rule to Improve Dialysis Patient Quality of Life

2020-03-21T20:41:19+00:00October 11th, 2019|Categories: Access to Transplant, Article, Charitable Premium Assistance, Comment Letter, Dental Coverage, Dialysis Funding, Innovation, Medicare Advantage, Quality Incentive Program, Treatment Options|

Each year—typically during the summer—the Centers for Medicare and Medicaid Services (CMS) puts out rules for how they are going to pay for dialysis treatment. The rules reflect CMS' latest policies, and organizations have the opportunity to provide feedback about the rules before they go into effect on January 1. DPC provided feedback to CMS regarding their end-stage renal disease (ESRD) Annual Payment rule. DPC's letter addresses the following important topics for improving ESRD patient care: Transitional Add-On Payment Adjustment for New and Innovative Equipment and Supplies Anemia Management Social Risk Factors and their Impact on the QIP The Need [...]

Insights from the Dialysis Patient Citizens 2018 Patient Survey: Patients’ Priorities for Quality Measures and New Innovations in ESRD Care

2020-03-21T20:41:50+00:00March 11th, 2019|Categories: Article, Innovation, Quality Incentive Program, Treatment Options|Tags: |

By Jackson Williams, Director of Regulatory Affairs and General Counsel, Dialysis Patient Citizens Dialysis Patient Citizens (DPC) thanks everyone who completed its 2018 Patient Survey. It is another way to make your voices heard. We use our patient survey to get your input on current issues and to convey your opinions to policymakers in Washington, DC. This year, our survey included questions on two recent developments in Washington: Medicare’s “Meaningful Measures” Initiative: In early 2018, Medicare officials announced plans to reduce the number of quality measures it uses to hold health care providers accountable. This meant that for dialysis care, [...]

Medicare Adds Transplant Measure to ESRD Quality Improvement Program

2020-03-21T20:41:51+00:00November 18th, 2018|Categories: Access to Transplant, Article, Quality Incentive Program|

On November 1, 2018, the Centers for Medicare & Medicaid Services (CMS) issued its final annual rule updating payment policies for the End-Stage Renal Disease (ESRD) Prospective Payment System and the ESRD Quality Incentive Program (QIP). Among new quality measures to take effect beginning in 2022 is Percentage of Prevalent Patients Placed on a Transplant Waiting List (PPPW). This measure was already scheduled to be reported for individual clinics, beginning next year, on CMS’ Dialysis Facility Compare website. Adding it to the QIP means that facilities can be penalized if the percentage of their patients waitlisted for transplant is below [...]

Advocacy for More Care Coordination

2020-03-21T20:42:25+00:00October 24th, 2018|Categories: Care Coordination, Quality Incentive Program|

DPC continues its advocacy in support of the Dialysis PATIENTS Demonstration Act (H.R. 4143/S. 2065), recently reaching out to members of both the House of Representatives and Senate. In our letters to Congress, we highlighted a number of important healthcare improvements for dialysis patients that are tied to the PATIENTS Act, including better care coordination, additional patient support and improved quality standards among clinics. DPC is joined by a number of organizations that agree on the potential benefits to patients in The Dialysis PATIENTS Act and have pledged their support. Click here to read DPC’s letter to the House of Representatives. [...]

DPC Comments on Annual Medicare ESRD Rule

2020-03-21T20:42:26+00:00August 29th, 2018|Categories: Comment Letter, Innovation, Quality Incentive Program|

Dialysis Patient Citizens sent its comment letter to the Centers for Medicare & Medicaid Services (CMS) expressing concerns and providing feedback on its End-Stage Renal Disease Prospective Payment System and Quality Incentive Program proposed payment rule (CMS-1691-P). The letter was informed by results from Dialysis Patient Citizen’s 2018 membership survey and focused on the following areas: Quality incentive program and the meaningful measures framework Transitional drug add-on payment adjustment and payments to reward innovation Request for information on price transparency Our hope is that by addressing these important topics, CMS will make amendments to the rule that will ultimately lead [...]

Annual Medicare ESRD Rule Highlights Innovation and “Meaningful Measures”

2020-03-21T20:42:26+00:00July 16th, 2018|Categories: Article, Innovation, Quality Incentive Program|

Last week, the Centers for Medicare & Medicaid Services (CMS) proposed what they called “innovative changes” to the payment rule for the End-Stage Renal Disease (ESRD) program. The rule includes a “proposal to address new renal dialysis drug and biological costs and foster innovations in treatment by incentivizing new therapies for patients on dialysis and a proposal to reduce facility-related documentation burden.” It contains the first changes to the ESRD Quality Incentive Program (QIP) since last year’s announcement of CMS’ “Meaningful Measures” Initiative. Funding for Dialysis The proposed 2019 ESRD base rate is $235.82, an increase of $3.45 to the current [...]

CMS Releases Proposed Payment Rule for 2018

2020-03-21T20:43:09+00:00July 19th, 2017|Categories: Article, Innovation, Quality Incentive Program|

On June 29, the Centers for Medicare & Medicaid Services (CMS) issued its proposed Annual Payment Rule for the End-Stage Renal Disease (ESRD) Program to govern dialysis services furnished beginning January 1, 2018. The proposed rule also makes minor changes to the ESRD Quality Incentive Program (QIP). This year’s rule includes an increase to the base rate, replacing QIP measures as well as including social risk factors in the QIP scores. CMS says the ESRD proposed rule is “one of several rules for 2018 that reflect a broader Administration-wide strategy to relieve regulatory burdens for providers; support the patient-doctor relationship [...]

CMS Updates Policies and Payment Rates for End-Stage Renal Disease Prospective Payment System (CMS 1651-F)

2020-03-21T20:44:12+00:00November 14th, 2016|Categories: Article, Dialysis Funding, Quality Incentive Program, Treatment Options|

On October 28, 2016, the Centers for Medicare & Medicaid Services (CMS) issued a final rule that updates payment policies and rates under the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for renal dialysis services furnished beginning January 1, 2017. Under the ESRD PPS for 2017, Medicare expects to pay approximately $9 billion to approximately 6,000 ESRD facilities to cover dialysis services. The finalized 2017 ESRD base rate will be $231.55. CMS projects that the updates for 2017 will increase total payments to all ESRD facilities by 0.73 percent compared with 2016, amounting to about $80 million. CMS is finalizing an increase to [...]

CMS Proposes Payment Updates for ESRD and New Policies for Quality Incentive Program (QIP)

2020-03-21T20:44:33+00:00July 4th, 2016|Categories: Article, Quality Incentive Program|

Each year, the Centers for Medicare & Medicaid Services (CMS) issue proposed rules to update payment rates under the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for renal dialysis services for the following year.  On June 24, 2016, CMS proposed updates to the PPS as well as new quality measures for 2017. Notably, CMS proposed an increase to the base rate paid to dialysis facilities of $0.65 in addition to proposing increasing the home and self-dialysis training payment. In regards to quality measures, CMS proposes the inclusion of a new “Safety Measure Domain” category for 2019, which would provide data on dialysis-events including [...]